Clinuvel Pharmaceuticals Limited ( CLVLF) - Key Metrics
CLVLF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.74 | $0.21 | $0.25 | $0.25 |
| 2025Q4 | $1.19 | $0.44 | $0.56 | $0.55 |
| 2025Q2 | $0.71 | $0.28 | $0.26 | $0.26 |
| 2024Q4 | $1.10 | $0.49 | $0.21 | $0.21 |
| 2024Q2 | $0.64 | $0.22 | $0.53 | $0.42 |
CLVLF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 24.00% | 14.96 |
| 2025Q4 | 0.00% | 5.88 |
| 2025Q2 | 17.79% | 10.77 |
| 2024Q4 | ? | 7.81 |
| 2024Q2 | 22.59% | 18.33 |
CLVLF Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.98% | 0.40% |
| 2025Q4 | 5.33% | 0.00% |
| 2025Q2 | 2.16% | 0.41% |
| 2024Q4 | 1.35% | ? |
| 2024Q2 | 2.63% | 0.31% |
CLVLF
Price: $7.27
Dividend Yield: 0.50%
Forward Dividend Yield: 0.90%
Payout Ratio: 7.08%
Dividend Per Share: 0.07 USD
Earnings Per Share: 0.46 USD
P/E Ratio: 18.13
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 329.7 million
Average Dividend Frequency: 2
Years Paying Dividends: 8
DGR3: 30.00%
DGR5: 30.00%